Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(6aS)-1,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol

EU orphan designation number: EU/3/13/1226   
Active ingredient: (6aS)-1,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol
Indication: Treatment of dystrophic myotonia
Sponsor: Valentia BioPharma S.L
C/Catedrático José Beltrán, 2, 46980 Paterna, España

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/01/2014 Orphan Designation EMA/OD/133/13 (2014)296 of 16/01/2014